nodes	percent_of_prediction	percent_of_DWPC	metapath
Encainide—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.247	0.247	CrCbGaD
Encainide—Eletriptan—HTR1B—attention deficit hyperactivity disorder	0.19	0.19	CrCbGaD
Encainide—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.123	0.123	CrCbGaD
Encainide—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.091	0.091	CrCbGaD
Encainide—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.0851	0.0851	CrCbGaD
Encainide—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.0846	0.0846	CrCbGaD
Encainide—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	0.0657	0.0657	CrCbGaD
Encainide—Thioridazine—DRD2—attention deficit hyperactivity disorder	0.0642	0.0642	CrCbGaD
Encainide—Thioridazine—HTR2A—attention deficit hyperactivity disorder	0.0496	0.0496	CrCbGaD
